- ►diabetesjournals.org S Nagamatsu, M Ohara-Imaizumi, Y Nakamichi, T … - Diabetes, 2006 - Am Diabetes Assoc Sulfonylurea and glinide drugs, commonly used for antidiabetes therapies, are known to stimulate
insulin release from pancreatic β-cells by closing ATP-sensitive K + channels. However, the
specific actions of these drugs on ... Cited by 5 - Related articles - BL Direct - All 5 versions
S Nagamatsu, M Ohara-Imaizumi, Y Nakamichi, T … - DIABETES, 2006 - Am Diabetes Assoc Page 1. Original Article Imaging Docking and Fusion of Insulin Granules Induced by
Antidiabetes Agents Sulfonylurea and Glinide Drugs Preferentially Mediate the Fusion of
Newcomer, but Not Previously Docked, Insulin Granules Shinya Nagamatsu ... Related articles
WJ Malaisse - Expert Opin. Pharmacother., 2008 - informahealthcare.com In 1994, four articles [1-4] were published concerning a novel rapid- and short-acting
non-sulfonylurea hypoglycemic agent, ie, compound KAD-1229 developed at Kissei Pharmaceutical Co.
Ltd (Japan). It was later proposed ... Cited by 1 - Related articles - All 7 versions
T Kikuta, M Ohara-Imaizumi, M Nakazaki, C Nishiwaki, … - FEBS letters, 2005 - Elsevier To explore how the sulfonylurea receptor (SUR1) is involved in docking and fusion of insulin
granules, dynamic motion of single insulin secretory granules near the plasma membrane was examined
in SUR1 knock-out (Sur1KO) β-cells ... Cited by 2 - Related articles - All 5 versions
[CITATION] GABA B-receptor activation inhibits exocytosis in rat pancreatic ß-cells by G-protein …
WJ Malaisse, B Dard-Brunelle - Research communications in molecular …, 1999 - ncbi.nlm.nih.gov The binding of tritiated S21403, a novel insulin-releasing agent of the meglitinide family, to
multilamellar liposomes formed of egg yolk phosphatidylcholine was compared to that of tritiated
glibenclamide. The binding of ... Cited by 2 - Related articles - BL Direct - All 2 versions
[CITATION] Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic …
K Ichikawa, T Yamato, A Tsuji, K Ojima, H … - Arzneimittel- …, 2002 - ncbi.nlm.nih.gov The insulinotropic effect of (+)-monocalcium bis [(2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-
carbonyl)propionate] dihydrate (CAS 145375-43-5, KAD-1229) was assessed by comparing it with those
of glibenclamide (CAS 10238-21-8), ... Cited by 2 - Related articles - BL Direct - All 2 versions
